Discovery of small molecules targeting the tandem tudor domain of the epigenetic factor UHRF1 using fragment-based ligand discovery
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Discovery of small molecules targeting the tandem tudor domain of the epigenetic factor UHRF1 using fragment-based ligand discovery ; volume:11 ; number:1 ; day:13 ; month:1 ; year:2021 ; pages:1-17 ; date:12.2021
Scientific reports ; 11, Heft 1 (13.1.2021), 1-17, 12.2021
- Urheber
-
Chang, Lyra
Campbell, James
Raji, Idris O.
Guduru, Shiva K. R.
Kandel, Prasanna
Nguyen, Michelle
Liu, Steven
Tran, Kevin
Venugopal, Navneet K.
Taylor, Bethany C.
Holt, Matthew V.
Young, Nicolas L.
Samuel, Errol L. G.
Jain, Prashi
Santini, Conrad
Sankaran, Banumathi
MacKenzie, Kevin R.
Young, Damian W.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-80588-4
- URN
-
urn:nbn:de:101:1-2021020723312877944385
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:40 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chang, Lyra
- Campbell, James
- Raji, Idris O.
- Guduru, Shiva K. R.
- Kandel, Prasanna
- Nguyen, Michelle
- Liu, Steven
- Tran, Kevin
- Venugopal, Navneet K.
- Taylor, Bethany C.
- Holt, Matthew V.
- Young, Nicolas L.
- Samuel, Errol L. G.
- Jain, Prashi
- Santini, Conrad
- Sankaran, Banumathi
- MacKenzie, Kevin R.
- Young, Damian W.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Epigenetic drug discovery
Epigenetic targets in drug discovery
Proteomics contributions to epigenetic drug discovery
Epigenetic assays for chemical biology and drug discovery
Proteome‐Wide Fragment‐Based Ligand and Target Discovery
Discovery and Characterization of Novel Proteasome Ligand Binding Sites
Chemical starting matter for HNF4α ligand discovery and chemogenomics
Discovery
The timeline of epigenetic drug discovery: from reality to dreams
Discovery of gorilla MHC-C expressing C1 ligand for KIR
High‐Throughput Kinetic Analysis for Target‐Directed Covalent Ligand Discovery
High‐Throughput Kinetic Analysis for Target‐Directed Covalent Ligand Discovery
Epigenetic drug discovery
Epigenetic targets in drug discovery
Proteomics contributions to epigenetic drug discovery
Epigenetic assays for chemical biology and drug discovery
Proteome‐Wide Fragment‐Based Ligand and Target Discovery
Discovery and Characterization of Novel Proteasome Ligand Binding Sites
Chemical starting matter for HNF4α ligand discovery and chemogenomics
Discovery
The timeline of epigenetic drug discovery: from reality to dreams
Discovery of gorilla MHC-C expressing C1 ligand for KIR
High‐Throughput Kinetic Analysis for Target‐Directed Covalent Ligand Discovery
High‐Throughput Kinetic Analysis for Target‐Directed Covalent Ligand Discovery
Epigenetic drug discovery
Epigenetic targets in drug discovery
Proteomics contributions to epigenetic drug discovery
Epigenetic assays for chemical biology and drug discovery
Proteome‐Wide Fragment‐Based Ligand and Target Discovery
Discovery and Characterization of Novel Proteasome Ligand Binding Sites
Chemical starting matter for HNF4α ligand discovery and chemogenomics
Discovery
The timeline of epigenetic drug discovery: from reality to dreams
Discovery of gorilla MHC-C expressing C1 ligand for KIR
High‐Throughput Kinetic Analysis for Target‐Directed Covalent Ligand Discovery